Krish S Krishnan sold $5.4M of KRYS
President and CEO at Krystal Biotech, Inc.. 35,873 shares at an average of $150.39, traded Jul 14, 2025, filed Jul 16, 2025.
Score components
- +25RoleCEO
- +25Trade size$5.4M at market
- 0Share of holdings soldSold 2.4% of holdings
- +8Cluster2 insiders selling within 14 days
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001298709-25-000009, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Jul 14, 2025 | SOpen-market sale Common Stock10b5-1 | -13,400 | $150.30 | $2.0M | 1,512,529 | Jul 16, 2025 |
| Jul 15, 2025 | SOpen-market sale Common Stock10b5-1 | -2,184 | $150.68 | $329k | 1,510,345 | Jul 16, 2025 |
| Jul 15, 2025 | SOpen-market sale Common Stock10b5-1 | -900 | $151.79 | $137k | 1,509,445 | Jul 16, 2025 |
| Jul 16, 2025 | SOpen-market sale Common Stock10b5-1 | -1,389 | $150.00 | $208k | 1,508,056 | Jul 16, 2025 |
| Jul 14, 2025 | SOpen-market sale Common Stockindirect: By Spouse10b5-1 | -13,335 | $150.29 | $2.0M | 1,443,376 | Jul 16, 2025 |
| Jul 14, 2025 | SOpen-market sale Common Stockindirect: By Spouse10b5-1 | -100 | $151.00 | $15k | 1,443,276 | Jul 16, 2025 |
| Jul 15, 2025 | SOpen-market sale Common Stockindirect: By Spouse10b5-1 | -2,236 | $150.68 | $337k | 1,441,040 | Jul 16, 2025 |
| Jul 15, 2025 | SOpen-market sale Common Stockindirect: By Spouse10b5-1 | -800 | $151.79 | $121k | 1,440,240 | Jul 16, 2025 |
| Jul 16, 2025 | SOpen-market sale Common Stockindirect: By Spouse10b5-1 | -1,529 | $150.00 | $229k | 1,438,711 | Jul 16, 2025 |
Related signals
Other insiders at Krystal Biotech, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 38Weak | Krystal Biotech, Inc. | Krish S Krishnan President and CEO | $9.0M 25,000 shares | -2% | |
| 33Weak | Krystal Biotech, Inc. | Suma Krishnan President, R&D | $9.0M 25,000 shares | -2% | |
| 33Weak | Krystal Biotech, Inc. | Suma Krishnan President, R&D | $5.4M 35,873 shares | -2% | |
| 38Weak | Krystal Biotech, Inc. | Krish S Krishnan President and CEO | $2.1M 14,127 shares | -1% | |
| 33Weak | Krystal Biotech, Inc. | Suma Krishnan President, R&D | $2.1M 14,127 shares | -1% | |
| 45Moderate | Krystal Biotech, Inc. | Krish S Krishnan President and CEO | $8.9M 50,000 shares | -3% | |
| 40Moderate | Krystal Biotech, Inc. | Suma Krishnan President, R&D | $8.9M 50,000 shares | -3% | |
| 6Weak | Krystal Biotech, Inc. | Kathryn Romano Chief Accounting Officer | $131k 750 shares | -6% | |
| 38Weak | Krystal Biotech, Inc. | Krish S Krishnan President and CEO | $8.2M 50,000 shares | -3% | |
| 33Weak | Krystal Biotech, Inc. | Suma Krishnan President, R&D | $8.2M 50,000 shares | -3% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.